This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
UltraSight Partners with SELVAS Healthcare to Develop and Commercialize AI-Powered Cardiac Ultrasound Software in Asia CI
MEDIANA Co.,Ltd announced that it has received KRW 16.78452058 billion in funding from Selvas AI Inc., SELVAS Healthcare, Inc. and other investors CI
MEDIANA Co.,Ltd announced that it expects to receive KRW 23.78451844 billion in funding from Selvas AI Inc., SELVAS Healthcare, Inc. and other investors CI
SELVAS Healthcare, Inc. agreed to acquire a 2.72% stake in Ultrasight Ltd. for KRW 1.4 billion. CI
SELVAS Healthcare, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Selvas Healthcare Plans 34.1 Billion Won Share Sale MT
SELVAS Healthcare, Inc. announced that it has received KRW 6 billion in funding from Ozoo I&A Co., Ltd. CI
Selvas AI Inc. cancelled the acquisition of additional 15.3% in SELVAS Healthcare, Inc.. CI
Selvas AI Inc. agreed to acquire additional 15.3% in SELVAS Healthcare, Inc. for KRW 4.5 billion. CI
SELVAS Healthcare, Inc. announced that it has received KRW 1.999998792 billion in funding from Selvas AI Inc. CI
SELVAS Healthcare, Inc. announced that it expects to receive KRW 1.999998792 billion in funding from Selvas AI Inc. CI
Infraware, Inc. completed the acquisition of 8.67% stake in SELVAS Healthcare, Inc. from Selvas AI Inc.. CI
Infraware, Inc. agreed to acquire 8.67% stake in SELVAS Healthcare, Inc. from Selvas AI Inc. for KRW 9 billion. CI
SELVAS Healthcare, Inc. announced that it has received KRW 6.999996945 billion in funding from Eum Private Equity, Industrial Bank of Korea, Investment Arm CI
SELVAS Healthcare, Inc. announced that it expects to receive KRW 6.99 billion in funding from Eum Private Equity, Industrial Bank of Korea, Investment Arm CI
Selvas Healthcare Inc Appoints Yoo Byung Tak as Chief Executive Officer CI
Tranche Update on SELVAS Healthcare, Inc.'s Equity Buyback Plan announced on October 10, 2016. CI
SELVAS Healthcare, Inc.'s Equity Buyback announced on October 10, 2016, has expired with 22,400 shares, representing 0.18% for KRW 79.08 million. CI
SELVAS Healthcare, Inc. announces an Equity Buyback for KRW 1,000 million worth of its shares. CI
SELVAS Healthcare, Inc. authorizes a Buyback Plan. CI
Jawonmedical. Co. Ltd. completed the acquisition of Hana Must Second Special Purpose Acquisition Company Ltd. in a reverse merger transaction. CI
Jawonmedical. Co. Ltd. agreed to acquire Hana Must Second Special Purpose Acquisition Company Ltd. in a reverse merger transaction. CI
Hana Must Second Special Purpose Acquisition Company Ltd. announced that it has received KRW 6.76 billion in funding from Timefolio Co.,Ltd. and other investors CI
Jawonmedical. Co. Ltd announced that it expects to receive KRW 6.76 billion in funding from Timefolio Co.,Ltd. and other investors CI
HIMS International Corporation acquired Jawonmedical. Co. Ltd for KRW 22.6 million. CI
Chart SELVAS Healthcare, Inc.
More charts
Selvas Healthcare Inc is a Korea-based company principally engaged in the manufacture and sale of medical devices. The Company is engaged in the manufacture and sale of body composition measuring instruments, blood pressure monitors, braille information terminals and other digital healthcare products. In addition, the Company is engaged in the development and sale of healthcare software. The Company was established in 1993.
More about the company

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. A208370 Stock
  4. News SELVAS Healthcare, Inc.
  5. Selvas Healthcare Plans 34.1 Billion Won Share Sale